Facility will manufacture materials that are vital to production of plasmid-based therapies and vaccines

High-resolution images of nanoparticles and beam-sensitive materials can now be obtained from a commercially available desktop SEM

1,200+ products to be identified for environmentally friendly capabilities and sustainability objectives

Strategic investments over the last two years expand global capabilities to support advanced therapies and large molecule development and manufacturing

Applied Biosystems RapidHIT ID DNA Booking System enables seamless integration of Rapid DNA into the law enforcement booking agency process

Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer; Karen E. Nelson joins the company as new CSO

Exclusive agreement to provide Thermo Scientific MAS Quality Controls for VITROS Analyzers

New media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies